Rapid emergence of echinocandin resistance in Candida glabrata resulting in clinical and microbiologic failure

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 9, 2013, Pages 4559-4561

  Lewis II, James S ^a,b   Wiederhold, Nathan P ^b   Wickes, Brian L ^c   Patterson, Thomas F ^b,d   Jorgensen, James H ^b  

^a UNIVERSITY HEALTH SYSTEM   (United States)

^b University of Texas Health Science Center   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; CASPOFUNGIN; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; ECHINOCANDIN; FLUCONAZOLE; GENOMIC DNA; GLUCOSE; MICAFUNGIN; PHENYLALANINE; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ACUTE PYELONEPHRITIS; ADD ON THERAPY; ADULT; ANION GAP; ANTIBIOTIC RESISTANCE; ANTIFUNGAL RESISTANCE; ARTICLE; BLOOD CULTURE; CANDIDA GLABRATA; CANDIDEMIA; CASE REPORT; CATHETER INFECTION; CATHETER REMOVAL; CEREBROVASCULAR ACCIDENT; CHILL; CHROMOSOME DELETION; CODON; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EMERGENCY WARD; ESCHERICHIA COLI; FEMALE; FEVER; FUNGUS ISOLATION; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOTENSION; INTENSIVE CARE UNIT; INTERNAL JUGULAR VEIN; INTRAVASCULAR CATHETER; LEUKOCYTE COUNT; MEDICAL HISTORY; MEDICAL SERVICE; METABOLIC ACIDOSIS; MINIMUM INHIBITORY CONCENTRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT TRANSPORT; POINT MUTATION; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; RESPIRATORY FAILURE; RESPIRATORY TRACT INTUBATION; RIGOR; RISK FACTOR; TACHYCARDIA; TREATMENT DURATION; URINE CULTURE; VOMITING;

ANTIFUNGAL AGENTS; CANDIDA GLABRATA; CANDIDEMIA; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; FEMALE; FUNGAL PROTEINS; GLUCOSYLTRANSFERASES; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUTATION; SEQUENCE ANALYSIS, DNA; TIME FACTORS;

EID: 84882374510     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01144-13     Document Type: Article

References (15)

1. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Jr, Calandra TF, Edwards JE, Jr, Filler SG, Fisher JF, Kullberg BJ, Ostrosky-Zeichner L, Reboli AC, Rex JH, Walsh TJ, Sobel JD, Infectious Diseases Society of America. 2009. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin. Infect. Dis. 48:503-535.
2. Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, Meersseman W, Akova M, Arendrup MC, Arikan-Akdagli S, Bille J, Castagnola E, Cuenca-Estrella M, Donnelly JP, Groll AH, Herbrecht R, Hope WW, Jensen HE, Lass-Florl C, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Viscoli C, Ullmann AJ, ESCMID Fungal Infection Study Group (EFISG). 2012. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: nonneutropenic adult patients. Clin. Microbiol. Infect. 18(Suppl 7):19-37.
3. Hope WW, Castagnola E, Groll AH, Roilides E, Akova M, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Cornely OA, Cuenca-Estrella M, Donnelly JP, Garbino J, Herbrecht R, Jensen HE, Kullberg BJ, Lass-Florl C, Lortholary O, Meersseman W, Petrikkos G, Richardson MD, Verweij PE, Viscoli C, Ullmann AJ, ESCMID Fungal Infection Study Group (EFISG). 2012. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. Clin. Microbiol. Infect. 18(Suppl 7):38-52.
4. Ullmann AJ, Akova M, Herbrecht R, Viscoli C, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Calandra T, Castagnola E, Cornely OA, Donnelly JP, Garbino J, Groll AH, Hope WW, Jensen HE, Kullberg BJ, Lass-Florl C, Lortholary O, Meersseman W, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Cuenca-Estrella M, ESCMID Fungal Infection Study Group (EFISG). 2012. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clin. Microbiol. Infect. 18(Suppl 7):53-67.
5. Andes DR, Safdar N, Baddley JW, Playford G, Reboli AC, Rex JH, Sobel JD, Pappas PG, Kullberg BJ, Mycoses Study Group. 2012. Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials. Clin. Infect. Dis. 54:1110-1122.
6. Alexander BD, Johnson MD, Pfeiffer CD, Jimenez-Ortigosa C, Catania J, Booker R, Castanheira M, Messer SA, Perlin DS, Pfaller MA. 2013. Increasing echinocandin resistance in Candida glabrata: clinical failure correlates with presence of FKS mutations and elevated minimum inhibitory concentrations. Clin. Infect. Dis. 57:1724-1732.
7. Pfeiffer CD, Garcia-Effron G, Zaas AK, Perfect JR, Perlin DS, Alexander BD. 2010. Breakthrough invasive candidiasis in patients on micafungin. J. Clin. Microbiol. 48:2373-2380.
8. CLSI. 2012. Reference method for broth dilution antifungal susceptibility testing of yeasts; fourth informational supplement. CLSI document M27-S4. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Shields RK, Nguyen MH, Press EG, Updike CA, Clancy CJ. 13 May 2013. Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure. Antimicrob. Agents Chemother. doi:10.1128/AAC.00136-13.
10. Thompson GR, III, Wiederhold NP, Vallor AC, Villareal NC, Lewis JS, II, Patterson TF. 2008. Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection. Antimicrob. Agents Chemother. 52:3783-3785.
11. Bautista-Munoz C, Boldo XM, Villa-Tanaca L, Hernandez-Rodriguez C. 2003. Identification of Candida spp. by randomly amplified polymorphicDNAanalysis and differentiation between Candida albicans and Candida dubliniensis by direct PCR methods. J. Clin. Microbiol. 41:414-420.
12. Becker K, Badehorn D, Deiwick S, Peters G, Fegeler W. 2000. Molecular genotyping of Candida species with special respect to Candida (Torulopsis) glabrata strains by arbitrarily primed PCR. J. Med. Microbiol. 49:575-581.
13. Meyer W, Latouche GN, Daniel HM, Thanos M, Mitchell TG, Yarrow D, Schonian G, Sorrell TC. 1997. Identification of pathogenic yeasts of the imperfect genus Candida by polymerase chain reaction fingerprinting. Electrophoresis 18:1548-1559.
14. Chong PP, Abdul Hadi SR, Lee YL, Phan CL, Tan BC, Ng KP, Seow HF. 2007. Genotyping and drug resistance profile of Candida spp. in recurrent and one-off vaginitis, and high association of non-albicans species with non-pregnant status. Infect. Genet. Evol. 7:449-456.
15. Garcia-Effron G, Lee S, Park S, Cleary JD, Perlin DS. 2009. Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint. Antimicrob. Agents Chemother. 53:3690-3699.